Christopher Yee
Genzyme
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christopher Yee.
Bioorganic & Medicinal Chemistry Letters | 2009
Yibin Xiang; Gary Asmussen; Michael Booker; Bradford Hirth; John L. Kane; Junkai Liao; Kevin D. Noson; Christopher Yee
Sphingosine kinase 1 (SK1) is an important enzyme that regulates the balance between ceramide and sphingosine-1-phosphate (S1P). Potent and novel SK1 inhibitors (6ag, 9ab and 12aa) have been discovered through a series of modifications of sphingosine (1), the substrate of this enzyme.
Bioorganic & Medicinal Chemistry Letters | 2010
Yibin Xiang; Bradford Hirth; John L. Kane; Junkai Liao; Kevin D. Noson; Christopher Yee; Gary Asmussen; Maria Fitzgerald; Christine Klaus; Michael Booker
Building on our initial work, we have identified additional novel inhibitors of sphingosine kinase-1 (SK1). These new analogs address the shortcomings found in our previously reported compounds. Inhibitors 51 and 54 demonstrated oral bioavailability in a rat PK study.
Bioorganic & Medicinal Chemistry | 1994
Helmut Kallwass; Christopher Yee; Todd Blythe; Thomas J. McNabb; Elizabeth Rogers; Spencer Shames
Abstract Aromatic α-amino-α-methyl acids and α-hydrazino-α-methyl acids are known aromatic amino acid decarboxylase inhibitors. Specific derivatives such as 2-amino-2-methyl-3-(3,4-dihydroxyphenyl)propanoate, Aldomet®, and 2-hydrazino-2-methyl-3-(3,4-dihydroxypheny Lodosyn®, have been developed as therapeutic agents to treat hypertension and Parkinsons disease, respectively. We recently reported a method for the kinetic resolution of the racemic esters of such compounds using a crude preparation of a novel enzyme catalyst from the yeast Candida lipolytica (Yee, C.; Blythe, T. A.; McNabb, T. J.; Walts, A. E. J. Org. Chem. 1992, 57, 3525-3527). Here we report the purification and initial characterization of the active enzyme component, an enzyme given the name Candida lipolytica ester hydrolase (CLEH). CLEH was purified to > 95% homogeneity by chromatography on MatrexTM Blue B resin. The enzyme was found to be a glycoprotcin with Mr = 80,000–300,000. In addition to esterolytic activity, the enzyme was found to catalyze the hydrolysis of amides, anilides and peptides. Sequence analysis of internal peptides of CLEH revealed striking homology to a number of enzymes belonging to the group of serine carboxypeptidases (E.G. 3.4.16.1). One peptide aligned with the canonical serine carboxypeptidase active site sequence, GESYAG. Based on the structural relationship of CLEH to serine carboxypeptidases, three representative serine carboxypeptidases were evaluated for their utility in resolving racemic α-tertiary ester substrates and compared with the activity of CLEH. All enzymes revealed similarly high activity and enantioselectivity towards the α-hydrazino-α-methyl ester precursor of the Parkinson-drug Carbidopa. However, differences in enantioselectivity were observed with other α-tertiary-substituted ester substrates. Serine carboxypeptidase-catalyzed ester resolutions thus offer a new route to many sterically hindered homochiral α-amino, α-hydrazino and α-hydroxy carboxylic acids.
Journal of Biological Chemistry | 2003
Mack Kuo; Héctor R. Morbidoni; David Alland; Scott F. Sneddon; Brian B. Gourlie; Marina Leonard; Jill S. Gregory; Andrew Janjigian; Christopher Yee; James M. Musser; Barry N. Kreiswirth; Hiroyuki Iwamoto; Remo Perozzo; William R. Jacobs; James C. Sacchettini; David A. Fidock
Journal of Organic Chemistry | 1992
Christopher Yee; Todd Blythe; Thomas J. McNabb; Alan E. Walts
Archive | 2000
Scott F. Sneddon; Christopher Yee; Andrew Janjigian
Archive | 2007
John L. Kane; Bradford Hirth; Christopher Yee; Hans-Peter Biemann; Marko J. Pregel
Archive | 2009
Yibin Xiang; Bradford Hirth; John L. Kane; Junkai Liao; Kevin D. Noson; Christopher Yee
Archive | 1992
Helmut Kalwass; Christopher Yee; Todd Blythe; Spencer Shames; Elizabeth Rogers
Archive | 1991
Christopher Yee; Todd Blythe; Alan E. Walts